Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis - Concepedia

Concepedia

Publication | Open Access

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

DOI Full Paper Access

127

Citations

30

References

2017

Year

Felicia Cosman, Paul D. Miller, Gregory C. Williams, Gary Hattersley, Ming‐yi Hu, Ivo Valter, Lorraine A. Fitzpatrick, Bente Juel Riis, Claus Christiansen, John P. Bilezikian,

Mayo Clinic Proceedings

Abstract

clinicaltrials.gov Identifier: NCT01657162.

References

	Year	Citations

Page 1